ALFATRAN stock news
This page provides real-time market news, earnings updates, and company announcements related to ALFA Transformers Limited (ALFATRAN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-30 21:01 IST
ImmunityBio's IBRX Places 398th in Trade Activity, Achieves 0.10% Increase as Key Study Enhances Optimism
101 finance2026-02-27 00:31:07
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway
Finviz2026-03-03 15:21:51
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-04 13:33:43
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
Freedom Capital Turns Cautious on Tennant (TNC), Downgrades Stock to Hold
Finviz2026-03-09 01:18:49
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
US Stock Alert: Immutep plunges 74.6% pre-market as lung cancer trial terminated due to efficacy and safety data review
格隆汇2026-03-13 09:18:08
ImmunityBio Shares Surge 7.29% on $260M Trading Volume Ranking 454th as Scalable NK-Cell Therapy Validation and Phase 1 Trial Safety Data Drive Investor Optimism
101 finance2026-03-14 01:01:04
An Intriguing Major Investor Is Wagering on a Stellantis Comeback — Is It Worth Your Consideration?
101 finance2026-03-14 09:30:47
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Biohaven’s Taldefgrobep Alfa Hinges on 2026 Phase 2 Obesity Trial: Can It Reroute the Weight-Loss S-Curve?
101 finance2026-03-19 12:03:58
Institutional Actions Following Immutep Indicate Smart Money’s Upcoming Strategy
101 finance2026-03-21 00:31:00
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:33:55
Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET
Finviz2026-03-23 12:33:50
The U.S. Food and Drug Administration (FDA) has taken regulatory action against biotechnology company ImmunityBio, Inc., issuing an official warning letter regarding promotional materials related to its anti-cancer drug Anktiva.
老虎证券2026-03-24 14:55:36
Convening Notice for Annual General Meeting of Shareholders
Finviz2026-03-25 21:03:55
Denali Receives FDA Approval for Hunter Syndrome Treatment, Shares Rise
101 finance2026-03-26 19:27:47
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:33:47
Bicara Therapeutics: Can It Walk the Tightrope Between Pivotal Trial Enrollment and a Looming Cash Crunch?
101 finance2026-03-30 11:54:51
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-04 13:33:43
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
Freedom Capital Turns Cautious on Tennant (TNC), Downgrades Stock to Hold
Finviz2026-03-09 01:18:49
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
US Stock Alert: Immutep plunges 74.6% pre-market as lung cancer trial terminated due to efficacy and safety data review
格隆汇2026-03-13 09:18:08
ImmunityBio Shares Surge 7.29% on $260M Trading Volume Ranking 454th as Scalable NK-Cell Therapy Validation and Phase 1 Trial Safety Data Drive Investor Optimism
101 finance2026-03-14 01:01:04
An Intriguing Major Investor Is Wagering on a Stellantis Comeback — Is It Worth Your Consideration?
101 finance2026-03-14 09:30:47
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Biohaven’s Taldefgrobep Alfa Hinges on 2026 Phase 2 Obesity Trial: Can It Reroute the Weight-Loss S-Curve?
101 finance2026-03-19 12:03:58
Institutional Actions Following Immutep Indicate Smart Money’s Upcoming Strategy
101 finance2026-03-21 00:31:00
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:33:55
Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET
Finviz2026-03-23 12:33:50
The U.S. Food and Drug Administration (FDA) has taken regulatory action against biotechnology company ImmunityBio, Inc., issuing an official warning letter regarding promotional materials related to its anti-cancer drug Anktiva.
老虎证券2026-03-24 14:55:36
Convening Notice for Annual General Meeting of Shareholders
Finviz2026-03-25 21:03:55
Denali Receives FDA Approval for Hunter Syndrome Treatment, Shares Rise
101 finance2026-03-26 19:27:47
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:33:47
Bicara Therapeutics: Can It Walk the Tightrope Between Pivotal Trial Enrollment and a Looming Cash Crunch?
101 finance2026-03-30 11:54:51
ALFATRAN stock price change
On the last trading day, ALFATRAN stock closed at 37.34 INR, with a price change of -1.79% for the day.
Trade stock perpsALFATRAN stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more